Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	240.34	382.76	310.68	154.09	211.43
Cash & Cash Equivalents	240.34	382.76	310.68	154.09	211.43
Cash Growth	-37.21%	23.20%	101.63%	-27.12%	11.69%
Other Current Assets	34.97	43.01	36.28	42.9	37.83
Total Current Assets	275.3	425.77	346.95	196.98	249.26
Property, Plant & Equipment	95.65	58.42	52.32	89.68	51.57
Long-Term Investments	0.98	1.83	2.04	2.63	2.04
Goodwill and Intangibles	0	0	0.07	0.16	0.25
Other Long-Term Assets	3.44	4.25	4.19	4.79	0.41
Total Long-Term Assets	100.08	64.5	58.61	97.25	54.28
Total Assets	375.38	490.27	405.56	294.24	303.53
Accounts Payable	0.46	0.65	0.56	2.26	1.08
Current Debt	5.05	5.04	4.45	3.59	2.51
Other Current Liabilities	39.22	40.68	23.54	27.78	21.4
Total Current Liabilities	44.74	46.37	28.55	33.63	24.98
Long-Term Debt	218.81	145.12	63.56	50.57	23.71
Other Long-Term Liabilities	0.36	0.12	0.13	0	0
Total Long-Term Liabilities	219.17	145.23	63.69	50.57	23.71
Total Liabilities	263.91	191.6	92.24	84.21	48.69
Total Debt	223.87	150.16	68.01	54.16	26.22
Debt Growth	49.09%	120.77%	25.58%	106.56%	-
Retained Earnings	-878.56	-670.18	-521.34	-379.24	-237.15
Comprehensive Income	-28.99	-38.9	-8.57	-5.86	-8.69
Shareholders' Equity	111.47	298.67	313.32	210.03	254.84
Net Cash / Debt	16.47	232.61	242.66	99.92	185.21
Net Cash / Debt Growth	-92.92%	-4.14%	142.85%	-46.05%	-2.16%
Net Cash Per Share	0.09	2.45	3.37	1.94	4.30
Working Capital	230.57	379.41	318.4	163.35	224.27
Book Value Per Share	0.64	3.14	4.35	4.07	5.92

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).